Thus, LOI of IGF-II will cause higher levels of free IGF-II promoting increased Survivin, among other proteins, and stimulating a more aggressive breast cancer progression and a breast tumor that is less responsive to chemotherapy. The gene discussed is IGF2; the disease is breast cancer.